ʻO ka PCR Fluorescence
-
Hepatitis E Virus
He mea kūpono kēia pahu no ka ʻike kūpono o ka maʻi hepatitis E (HEV) nucleic acid i loko o nā laʻana serum a me nā laʻana stool in vitro.
-
Hepatitis A Virus
He kūpono kēia pahu no ka ʻike ʻana i ka maʻi hepatitis A (HAV) nucleic acid i loko o nā laʻana serum a me nā laʻana stool in vitro.
-
Hepatitis B Virus RNA
Hoʻohana ʻia kēia pahu no ka ʻike ʻana i ka nui o ka maʻi hepatitis B RNA i loko o ka laʻana serum kanaka.
-
ʻO ka Hepatitis B Virus DNA Quantitative Fluorescence
Hoʻohana ʻia kēia pahu no ka ʻike nui ʻana o ka maʻi hepatitis B maʻi nucleic acid i loko o ka serum kanaka a i ʻole nā laʻana plasma.
-
HPV16 a me HPV18
He inte kēia pahunno ka in vitro qualitative detection of specific nucleic acid fragments of human papillomavirus (HPV) 16 and HPV18 in woman cervical exfoliated cell.
-
ʻEhiku Urogenital Pathogen
Hoʻohana ʻia kēia kit no ka ʻike qualitative o chlamydia trachomatis (CT), neisseria gonorrhoeae (NG) a me mycoplasma genitalium (MG), mycoplasma hominis (MH), herpes simplex virus type 2 (HSV2), ureaplasma parvum (UP) a me ureaplasma urealyticum (UU) nā ʻakika nucleic i loko o ka urethral swabs kāne a me ka wahine cervical swab samples in vitro, no ke kōkua ʻana i ka hōʻoia a me ka mālama ʻana i nā maʻi me nā maʻi maʻi genitourinary.
-
Mycoplasma Genitalium (Mg)
Hoʻohana ʻia kēia pahu no ka ʻike in vitro qualitative o Mycoplasma genitalium (Mg) nucleic acid i loko o ka ʻāpana mimi kāne a me nā mea huna huna wahine.
-
ʻO ka maʻi maʻi Dengue, Zika Virus a me Chikungunya Virus Multiplex
Hoʻohana ʻia kēia pahu no ka ʻike ʻana i ka maʻi dengue, ka maʻi Zika a me ka maʻi chikungunya nucleic acids i nā laʻana serum.
-
ʻO ke kanaka TEL-AML1 Fusion Gene Mutation
Hoʻohana ʻia kēia kit no ka ʻike kūpono o ka TEL-AML1 fusion gene i loko o nā ʻāpana iwi iwi kanaka i loko o ka vitro.
-
Mycobacterium Tuberculosis Nucleic Acid a me Rifampicin(RIF)，Isoniazid Resistance(INH)
He kūpono kēia huahana no ka ʻike qualitative o Mycobacterium tuberculosis DNA i loko o nā ʻāpana sputum kanaka i loko o ka vitro, a me ka homozygous mutation ma ka 507-533 amino acid codon region (81bp, rifampicin resistance determining region) o ka rpoB gene e kumu ai ka Mycobacterium tuberculosis kū'ē rifampicin.
-
17 Nā ʻano o ka HPV (16/18/6/11/44 Ke kikokiko ʻana)
He kūpono kēia pahu no ka ʻike qualitative o 17 mau ʻano papillomavirus (HPV) ʻano (HPV 6, 11, 16,18,31, 33,35, 39, 44,45, 51, 52.56,58, 59,66, 68) nā ʻāpana ʻakika nucleic kikoʻī i loko o ka laʻana mimi, ka laʻana o ka puʻu ʻana o ka ʻōpū o ka wahine a me ka laʻana o ka swab vaginal wahine, a me ka HPV 16/18/6/11/44 e paʻi ana e kōkua i ka ʻike a mālama ʻana i ka maʻi HPV.
-
ʻO Borrelia Burgdorferi Nucleic Acid
He kūpono kēia huahana no ka ʻike in vitro qualitative o Borrelia burgdorferi nucleic acid i loko o ke koko holoʻokoʻa o nā maʻi, a hāʻawi i nā ala kōkua no ka ʻike ʻana i nā maʻi maʻi Borrelia burgdorferi.
